ADEX
Home
People
Firms
Funds
Startups
Startups
Epicrispr Biotechnologies
epicrispr.com
Epigenetic neuromuscular therapy (EPI-321 for FSHD).
Team
No team members on record yet.
Investments
$68M
2025-03-26
Ally Bridge
SHOW MORE